|
|
Hepatitis Monthly، جلد ۱۴، شماره ۶، صفحات ۰-۰
|
|
|
| عنوان فارسی |
Risk Factors of HCV Seroconversion in Hemodialysis Patients in Tabriz, Iran |
|
| چکیده فارسی مقاله |
Conclusions The current study indicates increased risk for HCV infection in patients under dialysis and its relation with the mean duration of hemodialysis, history of renal transplantation and surgical intervention. Considering the immune deficiency in these patients, intense education to both patients and medical staff will be beneficial. Patients and Methods A retrospective analysis was performed on 455 hemodialysis patients from each of the five dialysis units in Tabriz, northwest Iran. Possible risk factors for HCV infection and seroconversion were evaluated. Results A total of 37 patients were HCV positive (8.1% of the study population) and seroconversion occurred in 18 of them during the dialysis treatment (3.95% of the study population). History of renal transplantation (44.4%, P < 0.0001), surgical intervention (except for renal transplantation and AV fistula placement) (94.4%, P = 0.03), and mean duration of dialysis (106.06 ± 55.519, P < 0.0001) had strong statistically significant associations with the seroconversion. Background Hepatitis C virus (HCV) infection is a significant health concern in patients with end-stage renal disease under dialysis. Epidemiological studies have reported a prevalence rate of 5.5-55.9% for this condition in Iran. Objectives We evaluated the risk factors for HCV infection and seroconversion in hemodialysis patients. |
|
| کلیدواژه‌های فارسی مقاله |
|
|
| عنوان انگلیسی |
Risk Factors of HCV Seroconversion in Hemodialysis Patients in Tabriz, Iran |
|
| چکیده انگلیسی مقاله |
Conclusions The current study indicates increased risk for HCV infection in patients under dialysis and its relation with the mean duration of hemodialysis, history of renal transplantation and surgical intervention. Considering the immune deficiency in these patients, intense education to both patients and medical staff will be beneficial. Patients and Methods A retrospective analysis was performed on 455 hemodialysis patients from each of the five dialysis units in Tabriz, northwest Iran. Possible risk factors for HCV infection and seroconversion were evaluated. Results A total of 37 patients were HCV positive (8.1% of the study population) and seroconversion occurred in 18 of them during the dialysis treatment (3.95% of the study population). History of renal transplantation (44.4%, P < 0.0001), surgical intervention (except for renal transplantation and AV fistula placement) (94.4%, P = 0.03), and mean duration of dialysis (106.06 ± 55.519, P < 0.0001) had strong statistically significant associations with the seroconversion. Background Hepatitis C virus (HCV) infection is a significant health concern in patients with end-stage renal disease under dialysis. Epidemiological studies have reported a prevalence rate of 5.5-55.9% for this condition in Iran. Objectives We evaluated the risk factors for HCV infection and seroconversion in hemodialysis patients. |
|
| کلیدواژه‌های انگلیسی مقاله |
|
|
| نویسندگان مقاله |
محمد حسین صومی | mohammad hossein somi
liver and gastrointestinal disease research center, tabriz university of medical sciences, tabriz, ir iran
سازمان اصلی تایید شده: دانشگاه علوم پزشکی تبریز (Tabriz university of medical sciences)
جلال اعتمادی | jalal etemadi
chronic kidney diseases research center, tabriz university of medical sciences, tabriz, ir iran
سازمان اصلی تایید شده: دانشگاه علوم پزشکی تبریز (Tabriz university of medical sciences)
مرتضی قوجازاده | morteza ghojazadeh
liver and gastrointestinal disease research center, tabriz university of medical sciences, tabriz, ir iran
سازمان اصلی تایید شده: دانشگاه علوم پزشکی تبریز (Tabriz university of medical sciences)
سارا فرهنگ | sara farhang
cliniclal psychiatry research center, tabriz university of medical sciences, tabriz, ir iran
سازمان اصلی تایید شده: دانشگاه علوم پزشکی تبریز (Tabriz university of medical sciences)
مهرآسا فرامرزی | mehrasa faramarzi
liver and gastrointestinal disease research center, tabriz university of medical sciences, tabriz, ir iran
سازمان اصلی تایید شده: دانشگاه علوم پزشکی تبریز (Tabriz university of medical sciences)
ساناز فروتن | sanaz foroutan
liver and gastrointestinal disease research center, tabriz university of medical sciences, tabriz, ir iran
سازمان اصلی تایید شده: دانشگاه علوم پزشکی تبریز (Tabriz university of medical sciences)
مریم سلیمانپور | maryam soleimanpour
liver and gastrointestinal disease research center, tabriz university of medical sciences, tabriz, ir iran; corresponding author maryam soleimanpour, liver and gastrointestinal disease research center, imam reza hospital, tabriz university of medical sciences, golgasht st., tabriz, ir iran. tel 98-4113367473, fax 98-4113367499, e-mail
سازمان اصلی تایید شده: دانشگاه علوم پزشکی تبریز (Tabriz university of medical sciences)
|
|
| نشانی اینترنتی |
http://www.hepatmon.com/index.php?page=article&article_id=17417 |
| فایل مقاله |
فایلی برای مقاله ذخیره نشده است |
| کد مقاله (doi) |
10.5812/hepatmon.17417 |
| زبان مقاله منتشر شده |
fa |
| موضوعات مقاله منتشر شده |
|
| نوع مقاله منتشر شده |
research-article |
|
|
|
برگشت به:
صفحه اول پایگاه |
نسخه مرتبط |
نشریه مرتبط |
فهرست نشریات
|